Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.

Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A.

J Clin Oncol. 2005 Aug 20;23(24):5511-9.

PMID:
16110011
2.

Medulloblastomas and central nervous system primitive neuroectodermal tumors.

McLean TW.

Curr Treat Options Oncol. 2003 Dec;4(6):499-508. Review.

PMID:
14585230
3.

[Medulloblastoma: analysis of 14 cases treated at the J. Bordet Institute and literature review].

Ismaili K, Sariban E, Otten J, Regnier R.

Rev Med Brux. 1992 Mar;13(3):51-60. Review. French.

PMID:
1561501
4.

[Childhood medulloblastoma].

Yazigi-Rivard L, Masserot C, Lachenaud J, Diebold-Pressac I, Aprahamian A, Avran D, Doz F.

Arch Pediatr. 2008 Dec;15(12):1794-804. doi: 10.1016/j.arcped.2008.09.021. Review. French.

PMID:
18995998
5.

Medulloblastoma in young children.

Rutkowski S, Cohen B, Finlay J, Luksch R, Ridola V, Valteau-Couanet D, Hara J, Garre ML, Grill J.

Pediatr Blood Cancer. 2010 Apr;54(4):635-7. doi: 10.1002/pbc.22372. Review.

PMID:
20146217
6.

Childhood medulloblastoma: progress and future challenges.

Packer RJ.

Brain Dev. 1999 Mar;21(2):75-81. Review.

PMID:
10206522
7.

Late neurocognitive sequelae in survivors of brain tumours in childhood.

Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE.

Lancet Oncol. 2004 Jul;5(7):399-408. Review.

PMID:
15231246
8.

Risk-adapted chemotherapy in childhood medulloblastoma.

Varan A.

Expert Rev Anticancer Ther. 2011 May;11(5):771-80. doi: 10.1586/era.10.222. Review.

PMID:
21554052
9.

The therapy of infantile malignant brain tumors: current status?

Kalifa C, Grill J.

J Neurooncol. 2005 Dec;75(3):279-85. Review.

PMID:
16195802
10.
11.

Childhood medulloblastoma.

Walker RW, Rosenblum MK.

Rev Neurol (Paris). 1992;148(6-7):467-76. Review.

PMID:
1448667
12.

Understanding the cognitive impact on children who are treated for medulloblastoma.

Palmer SL, Reddick WE, Gajjar A.

J Pediatr Psychol. 2007 Oct;32(9):1040-9. Review.

13.

Review of the molecular genetics and chemotherapeutic treatment of adult and paediatric medulloblastoma.

Newton HB.

Expert Opin Investig Drugs. 2001 Dec;10(12):2089-104. Review.

PMID:
11772307
14.

Current treatment of medulloblastoma: recent advances and future challenges.

Rood BR, Macdonald TJ, Packer RJ.

Semin Oncol. 2004 Oct;31(5):666-75. Review.

PMID:
15497120
15.

Impact of radiation technique upon the outcome of treatment for medulloblastoma.

Halperin EC.

Int J Radiat Oncol Biol Phys. 1996 Aug 1;36(1):233-9. Review.

PMID:
8823280
16.

Cognitive disorders in pediatric medulloblastoma: what neuroimaging has to offer.

Hoang DH, Pagnier A, Guichardet K, Dubois-Teklali F, Schiff I, Lyard G, Cousin E, Krainik A.

J Neurosurg Pediatr. 2014 Aug;14(2):136-44. doi: 10.3171/2014.5.PEDS13571. Review.

PMID:
24950472
17.

Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study.

Copeland DR, deMoor C, Moore BD 3rd, Ater JL.

J Clin Oncol. 1999 Nov;17(11):3476-86. Review.

PMID:
10550145
18.

Neurodevelopmental impact on children treated for medulloblastoma: a review and proposed conceptual model.

Palmer SL.

Dev Disabil Res Rev. 2008;14(3):203-10. doi: 10.1002/ddrr.32. Review.

19.

Management of pediatric and adult patients with medulloblastoma.

Martin AM, Raabe E, Eberhart C, Cohen KJ.

Curr Treat Options Oncol. 2014 Dec;15(4):581-94. doi: 10.1007/s11864-014-0306-4. Review.

20.

Medulloblastoma.

Bailey CC.

Arch Dis Child. 1992 May;67(5):572-3. Review. No abstract available.

Items per page

Supplemental Content

Support Center